One of the outstanding issues of modern medicine is to combat pain effectively. Jose Vicente Torres Pérez, a Spanish researcher who works at Imperial College in London, set out to curb the suffering of people with serious burns.
Torres found that blocking a new genetic marker can reduce the neural activation caused by painful stimuli.
As Torres, the only Spanish researcher participating in the study published today in the journal ‘Scientific Reports’, explains to SINC: “The cell activation markers most used today are pERK1/2 and c-Fos, but both have their limitations.”
The development and persistence of pain depends on plastic changes to the neurons that process information on noxious stimuli, which are those of the dorsal spinal cord.
These plastic changes are largely regulated by epigenetic mechanisms, i.e. chemical changes that alter the expression of the genes, but not their sequence, such as post-translational modifications of histones.
“Seeking new pain markers continues to be very important in the field of nociception, which analyses the subjective experience of pain, and a need that has not yet been met,” adds Torres Pérez.
New pain relief therapy
Technically, the team in which the Spanish expert works has demonstrated in mice that a population of superficial neurons in the spinal cord controls an epigenetic marker known as pS10H3.
“We observed the effect after using various animal pain models: inducing burns, applying capsaicin or electrical nerve stimulation,” explains Torres Pérez. Therefore, the authors believe that, if this activation is blocked, they will achieve a new pain relief therapy.
For the Spanish researcher, “pS10H3 is a new marker of pain processing in neurons on the spinal cord, and the changes caused by it are fundamental to normal pain development, which opens up new therapeutic possibilities.”
Application to burn victims
Recent advances have significantly increased the survival rates of burn victims, but little has been achieved to alleviate the pain they suffer.
According to the authors, advances that help to decipher the molecular mechanisms produced in neurons that are key to processing pain – such as the discovery of this alteration – will help to find new therapeutic strategies.
“We propose that blocking this epigenetic modification could be a new strategy to try to reduce or completely eliminate the pain after these processes,” Torres Pérez concludes.
[osd_subscribe categories=’Epigenetics’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “EPIGENETICS”‘]
Receive an email update when we add a new EPIGENETICS article.
The Latest on: Epigenetics
via Google News
The Latest on: Epigenetics
- Global Epigenetics Drugs And Diagnostic Technologies Market Size Is Expected To Grow At A CAGR Of Approx. 21% From 2022 To 2032on August 5, 2022 at 2:24 pm
Evolve Business Intelligence published a new market research report on Global Epigenetics Drugs And Diagnostic Technologies Market By Type (Epigenetic Drugs (DNMT Inhibitors (Azacitidine ...
- We Need to Talk, with Toni Street: Kate Hawkesby on getting Covid, nutrition and epigeneticson August 4, 2022 at 4:52 pm
In this episode of We Need To Talk, Toni Street catches up with Newstalk ZB host and contributor Kate Hawkesby. Kate, who is passionate about wellness, opens up about getting sick with Covid-19 and ...
- Epigenetics Market |(CAGR) of 14.9%| with Key-Players Strategies | Growth, Business Prospects and Industry Updates with Forecast 2030on August 4, 2022 at 3:13 am
Aug 04, 2022 (Alliance News via COMTEX) -- The global epigenetics market size was US$ 1.14 billion in 2021. The global epigenetics market size is forecast to reach US$ 5.1 billion by 2030 ...
- Epigenetics Market – 2022 by Manufacturers, Regions, Size, Share, Forecast to 2028on August 3, 2022 at 12:59 am
New Jersey, United States – Epigenetics Market 2022 – 2028, Size, Share, and Trends Analysis Research Report Segmented with Type, Component, Application, Growth Rate, Region, and Forecast ...
- Epigenetics Market Size is projected to reach USD 11.83 billion by 2030, growing at a CAGR of 17.05%: Straits Researchon August 2, 2022 at 5:06 am
New York, United States, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Epigenetics explores how cells affect gene function without changing DNA. "Epigenetic" refers to elements above the genetic code.
- Epigenetics Market Share, Growth, Trends and Forecast to 2025| Thermo Fisher Scientific, Merck Millipore, Abcamon July 28, 2022 at 5:00 pm
QY Research has recently published a new report, titled Epigenetics Market- Global Industry Analysts 2019 – 2025. The report has been put together using primary and secondary research ...
- Epigenetics Market worth $3.9 billion by 2027 - Exclusive Report by MarketsandMarkets(TM)on July 28, 2022 at 7:49 am
Epigenetics Market is valued at USD 1.7 billion in 2022 and is expected to reach USD 3.9 billion by 2027 at a CAGR of 18.1% during the forecast period, according to a new report by MarketsandMarkets ...
- Epigenetics Market worth $3.9 billion by 2027 – Exclusive Report by MarketsandMarkets™on July 28, 2022 at 7:30 am
Epigenetics Market is valued at USD 1.7 billion in 2022 and is expected to reach USD 3.9 billion by 2027 at a CAGR of 18.1% during the forecast period, according to a new report by ™. The demand for ...
via Bing News